Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.

Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.

J Clin Psychiatry. 2010 Sep;71(9):1125-30. doi: 10.4088/JCP.09m05086blu. Epub 2010 Apr 20.

PMID:
20441723
2.

A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.

Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M.

Contemp Clin Trials. 2009 May;30(3):205-11. doi: 10.1016/j.cct.2009.01.007. Epub 2009 Jan 24.

PMID:
19470312
3.

Escitalopram continuation treatment prevents relapse of depressive episodes.

Rapaport MH, Bose A, Zheng H.

J Clin Psychiatry. 2004 Jan;65(1):44-9.

PMID:
14744167
4.

Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

Khajavi D, Farokhnia M, Modabbernia A, Ashrafi M, Abbasi SH, Tabrizi M, Akhondzadeh S.

J Clin Psychiatry. 2012 Nov;73(11):1428-33. doi: 10.4088/JCP.12m07706. Epub 2012 Oct 16.

PMID:
23146150
5.

Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C.

J Clin Psychiatry. 2006 Nov;67(11):1767-75.

PMID:
17196058
6.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
7.

Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.

Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, Álvarez E, Artigas F, Pérez V.

J Clin Psychiatry. 2011 Jul;72(7):962-9. doi: 10.4088/JCP.09m05827blu. Epub 2010 Oct 19.

PMID:
21034693
8.

An open-label study of citalopram for major depression following traumatic brain injury.

Rapoport MJ, Chan F, Lanctot K, Herrmann N, McCullagh S, Feinstein A.

J Psychopharmacol. 2008 Nov;22(8):860-4. doi: 10.1177/0269881107083845. Epub 2008 Jan 21.

PMID:
18208921
9.

Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).

Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH.

J Clin Psychiatry. 2009 Feb;70(2):232-7. Epub 2009 Jan 13.

PMID:
19192459
10.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
11.

A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer.

Lydiatt WM, Denman D, McNeilly DP, Puumula SE, Burke WJ.

Arch Otolaryngol Head Neck Surg. 2008 May;134(5):528-35. doi: 10.1001/archotol.134.5.528.

PMID:
18490576
12.

Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.

Rosenberg C, Lauritzen L, Brix J, Jørgensen JB, Kofod P, Bayer LB.

Psychopharmacol Bull. 2007;40(1):63-73.

PMID:
17285097
13.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
14.
15.

An open-label trial of citalopram for major depression in patients with hepatitis C.

Gleason OC, Yates WR, Isbell MD, Philipsen MA.

J Clin Psychiatry. 2002 Mar;63(3):194-8.

PMID:
11926717
17.

Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.

Zisook S, Kasckow JW, Lanouette NM, Golshan S, Fellows I, Vahia I, Mohamed S, Rao S.

J Clin Psychiatry. 2010 Jul;71(7):915-22. doi: 10.4088/JCP.09m05699gre. Epub 2010 Mar 9.

PMID:
20361918
18.

Escitalopram prevents relapse in older patients with major depressive disorder.

Gorwood P, Weiller E, Lemming O, Katona C.

Am J Geriatr Psychiatry. 2007 Jul;15(7):581-93.

PMID:
17586783
19.

Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients.

Pompili M, Baldessarini RJ, Tondo L, Innamorati M, Tatarelli R, Girardi P, De Pisa E.

J Affect Disord. 2010 Apr;122(1-2):154-8. doi: 10.1016/j.jad.2009.07.018. Epub 2009 Aug 25.

PMID:
19709752
20.

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.

J Clin Psychiatry. 2003 Sep;64(9):1065-74.

PMID:
14628982

Supplemental Content

Support Center